Skip to main content

CAPITAL FUND MANAGEMENT S.A.

Position in OGN — Organon & Co.

CIK 1323645 PARIS, I0

Position in OGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
15 quarters on record

Common Shares in OGN Over Time

Shares Held

Position Value (USD)

Derivatives in OGN

reported options exposure · as of Jun 30, 2026
CallValue
$1,172,564
CallShares
86,600
PutValue
$1,144,130
PutShares
84,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CAPITAL FUND MANAGEMENT S.A. holds $132,289,562 across 6 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in OGN

Export CSV
31 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,172,564 86,600
2026-06-30 $1,144,130 84,500
2026-03-31 $925,455 154,500
2026-03-31 $669,083 111,700
2025-12-31 $3,197,103 445,900
2025-12-31 $1,857,030 259,000
2025-12-31 $2,747,544 383,200
2025-09-30 $4,919,208 460,600
2025-09-30 $6,405,864 599,800
2025-09-30 $1,682,634 157,550
2025-06-30 $3,892,734 402,142
2025-06-30 $4,185,632 432,400
2025-06-30 $5,385,952 556,400
2025-03-31 $5,285,950 355,000
2025-03-31 $4,630,790 311,000
2024-12-31 $1,651,644 110,700
2024-12-31 $4,577,456 306,800
2024-09-30 $1,450,054 75,800
2024-09-30 $7,116,360 372,000
2024-06-30 $1,805,040 87,200
2024-06-30 $7,748,010 374,300
2024-03-31 $10,522,360 559,700
2024-03-31 $6,617,600 352,000
2023-12-31 $7,238,840 502,000
2023-12-31 $3,850,140 267,000
2023-09-30 $3,812,256 219,600
2023-09-30 $4,060,504 233,900
2023-06-30 $2,557,549 122,900
2023-06-30 $4,164,081 200,100
2023-03-31 $585,648 24,900
2021-06-30 $316,822 10,470